The findings suggest that MBD3 plays an important role in multiple aspects of colon cancer, especially the EMT process, which promotes metastases and leads to poor prognoses, and has potential biological value as a novel therapeutic target. This evidence concerns the gene MBD3 and malignant colon neoplasm.